Who is this meeting intended for?
The meeting is aimed at Swedish actors, including companies, the public sector, and academia, that are interested in applying for funding from Vinnova to participate in a call for proposals in cell and gene therapies through the European Partnership for Precision Medicine (EP PerMed).
Agenda
The meeting is led by Vinnova and describes how Swedish actors goes about applying for funding to ensure Swedish participation in the call for proposals.
- Information About the EP PerMed Partnership
- Description of the call for proposals and practical information on how to apply
Participate in the meeting
The meeting takes place digitally via Teams.
In the call for proposals
The European Partnership for Personalized Medicine (EP PerMed) will launch a Call for Proposals (call for proposals) in November 2026 (JTC 2027) focused on developing and validating cell and gene therapies in the field of precision medicine. Vinnova and the Swedish Research Council are funding Swedish participation.
The call for proposals on Vinnova's website